Toward Optimized Zr-89-Immuno-PET: Side-by-Side Comparison of [Zr-89]Zr-DFO-, [Zr-89]Zr-3,4,3-(LI-1,2-HOPO)- and [Zr-89]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?-MedSci.cn - 梅斯（MedSci）

Toward Optimized Zr-89-Immuno-PET: Side-by-Side Comparison of [Zr-89]Zr-DFO-, [Zr-89]Zr-3,4,3-(LI-1,2-HOPO)- and [Zr-89]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?

Damerow, H; Cheng, X; von Kiedrowski, V; Schirrmacher, R; Wangler, B; Fricker, G; Wangler, C

Wangler, C (通讯作者)，Heidelberg Univ, Med Fac Mannheim, Clin Radiol & Nucl Med, Biomed Chem, D-68167 Mannheim, Germany.

PHARMACEUTICS, 2022; 14 (10):

Abstract

Zr-89 represents a highly favorable positron emitter for application in immuno-PET (Positron Emission Tomography) imaging. Clinically, the Zr-89(4+) i......

Full Text Link

Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

科室
- - 订阅+
  - 更多科室
工具
服务